• español
  • English
  • français
  • Deutsch
  • português (Brasil)
  • italiano
    • español
    • English
    • français
    • Deutsch
    • português (Brasil)
    • italiano
    • español
    • English
    • français
    • Deutsch
    • português (Brasil)
    • italiano
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Parcourir

    Tout UVaDOCCommunautésPar date de publicationAuteursSujetsTitres

    Mon compte

    Ouvrir une session

    Statistiques

    Statistiques d'usage de visualisation

    Compartir

    Voir le document 
    •   Accueil de UVaDOC
    • PUBLICATIONS SCIENTIFIQUES
    • Departamentos
    • Dpto. Medicina, Dermatología y Toxicología
    • DEP52 - Artículos de revista
    • Voir le document
    •   Accueil de UVaDOC
    • PUBLICATIONS SCIENTIFIQUES
    • Departamentos
    • Dpto. Medicina, Dermatología y Toxicología
    • DEP52 - Artículos de revista
    • Voir le document
    • español
    • English
    • français
    • Deutsch
    • português (Brasil)
    • italiano

    Exportar

    RISMendeleyRefworksZotero
    • edm
    • marc
    • xoai
    • qdc
    • ore
    • ese
    • dim
    • uketd_dc
    • oai_dc
    • etdms
    • rdf
    • mods
    • mets
    • didl
    • premis

    Citas

    Por favor, use este identificador para citar o enlazar este ítem:http://uvadoc.uva.es/handle/10324/5836

    Título
    Antibodies against Chlamydia pneumoniae and their relation to lymphocyte population levels
    Autor
    González Castañeda, Candelas
    Pérez Castrillon, José LuisAutoridad UVA
    Romero Gómez, Mercedes
    Herreros Fernández, Vicente
    Año del Documento
    2002
    Editorial
    Elsevier Science Ireland Ltd.
    Descripción
    Producción Científica
    Documento Fuente
    International Journal of Cardiology, 2002, vol. 82, p. 293-295
    Résumé
    Chlamydia pneumoniae infection has long been suspected as a possible cause of atherosclerosis and has been frequently detected in atheromatous plaques of the coronary arteries. Nevertheless, its distribution is not correlated to the severity or extent of the disease, but it would support the hypothesis that the organism may be an active factor in the pathogenesis of atherosclerosis. A group of patients with stable angina were examined as to whether or not the positivity of antibodies against Chlamydia pneumoniae modified cellular populations as mechanisms responsible for the alterations of inflammatory response. We concluded that the presence of IgG anti-C. pneumoniae antibodies do not participate in the activation of inflammatory mechanisms that may intervene in the genesis of atherosclerosis in patients with stable angina.
    Materias (normalizadas)
    Cardiovascular, Aparato, Efectos de los medicamentos sobre el
    Atherosclerosis
    Neumonia
    ISSN
    0167-5273
    Revisión por pares
    SI
    Idioma
    eng
    URI
    http://uvadoc.uva.es/handle/10324/5836
    Derechos
    openAccess
    Aparece en las colecciones
    • DEP52 - Artículos de revista [181]
    Afficher la notice complète
    Fichier(s) constituant ce document
    Nombre:
    CASTRILLON 10[1].pdf
    Tamaño:
    38.27Ko
    Formato:
    Adobe PDF
    Descripción:
    PD-83
    Thumbnail
    Voir/Ouvrir
    Attribution-NonCommercial-NoDerivatives 4.0 InternationalExcepté là où spécifié autrement, la license de ce document est décrite en tant que Attribution-NonCommercial-NoDerivatives 4.0 International

    Universidad de Valladolid

    Powered by MIT's. DSpace software, Version 5.10